BMY
Bristol-Myers Squibb Co
Price:  
59.12 
USD
Volume:  
11,691,090.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Bmy WACC - Weighted Average Cost of Capital

The WACC of Bristol-Myers Squibb Co (BMY) is 6.3%.

The Cost of Equity of Bristol-Myers Squibb Co (BMY) is 7.25%.
The Cost of Debt of Bristol-Myers Squibb Co (BMY) is 4.40%.

Range Selected
Cost of equity 6.10% - 8.40% 7.25%
Tax rate 16.00% - 22.80% 19.40%
Cost of debt 4.00% - 4.80% 4.40%
WACC 5.4% - 7.2% 6.3%
WACC

Bmy WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.49 0.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 8.40%
Tax rate 16.00% 22.80%
Debt/Equity ratio 0.33 0.33
Cost of debt 4.00% 4.80%
After-tax WACC 5.4% 7.2%
Selected WACC 6.3%